Thoracic and Cardiac Surgery
Thoracic and Cardiac Surgery
Faculty Rank: Professor
Medical or Graduate Education:
Northwestern University Feinberg School of Medicine
Barnes-Jewish Hospital - Surgery
Brigham and Women's Hospital - Thoracic Surgery
Cancer surgery, lung
Video-assisted thoracoscopic surgery (VATS)
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution. Sher DJ, Liptay MJ, Fidler MJ Int. J. Radiat. Oncol. Biol. Phys. 2014 Jun 1 89(2):303-12. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Sher DJ, Koshy M, Liptay MJ, Fidler MJ Cancer 2014 Apr 1 Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection. Garg S, Gielda BT, Turian JV, Liptay M, Warren WH, Bonomi P, Sher DJ Pract Radiat Oncol 2013 Oct-Dec 3(4):287-93. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. Daly S, Rinewalt D, Fhied C, Basu S, Mahon B, Liptay MJ, Hong E, Chmielewski G, Yoder MA, Shah PN, Edell ES, Maldonado F, Bungum AO, Borgia JA. J Thorac Oncol. 2013 2013 Jan 8(1):31-6. doi: 10.1097/JTO.0b013e31827627f8. Multimodality treatment of pleural mesothelioma. Shersher DD, Liptay MJ. Surg Oncol Clin N Am. 2013 2013 Apr 22(2):345-55. doi: 10.1016/j.soc.2012.12.004. Epub 2012 Dec 29. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M. Ann Oncol. 2012 May 23(5):1095-103. Anterior mediastinal mass secondary to histoplasmosis. Shersher DD, Hong E, Breard J, Warren WH, Liptay MJ. Ann Thorac Surg. 2012 2012 Jan 93(1):e9-10. doi: 10.1016/j.athoracsur.2011.07.093. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P. Clin Lung Cancer. 2012 2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print] CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients. Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, Buckingham L. Diagn Mol Pathol. 2012 2012 Dec 21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. Rinewalt D, Shersher DD, Daly S, Fhied C, Basu S, Mahon B, Hong E, Chmielewski G, Liptay MJ, Borgia JA. J Thorac Cardiovasc Surg. 2012 2012 Dec 144(6):1344-50; discussion 1350-1. doi: 10.1016/j.jtcvs.2012.08.033. Epub 2012 Sep 13. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP. Int J Radiat Oncol Biol Phys. 2011 2011 Nov 15 81(4):985-91. doi: 10.1016/j.ijrobp.2010.06.059. Epub 2010 Oct 6. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA. Ann Thorac Surg. 2011 2011 Nov 92(5):1805-11; discussion 1811. doi: 10.1016/j.athoracsur.2011.06.058. Epub 2011 Sep 25. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P. J Thorac Oncol. 2011 2011 Jun 6(6):1079-86. doi: 10.1097/JTO.0b013e3182199a7c. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Patel K, Farlow EC, Kim AW, Lee BS, Basu S, Coon JS, DeCresce D, Thimothy L, Walters KA, Fhied C, Chang C, Chen SH, Faber LP, Bonomi P, Liptay MJ, Borgia JA. Int J Cancer. 2011 2011 Jul 1 129(1):133-42. doi: 10.1002/ijc.25644. Epub 2010 Nov 9. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP. Ann Thorac Surg. 2011 2011 Jul 92(1):233-41; discussion 241-3. doi: 10.1016/j.athoracsur.2011.03.001. Epub 2011 May 28. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ. Lung Cancer. 2011 2011 Feb 71(2):186-90. doi: 10.1016/j.lungcan.2010.05.006. Epub 2010 Jun 8. Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis. Shersher DD, Hong E, Warren W, Penfield Faber L, Liptay MJ. Ann Thorac Surg. 2011 2011 Dec 92(6):e113-4. doi: 10.1016/j.athoracsur.2011.06.025. The early years: how to set up and build your practice. Liptay MJ. Thorac Surg Clin. 2011 2011 Aug 21(3):341-7. doi: 10.1016/j.thorsurg.2011.04.002. STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Kozower BD, Sheng S, O'Brien SM, Liptay MJ, Lau CL, Jones DR, Shahian DM, Wright CD. Ann Thorac Surg. 2010 2010 Sep 90(3):875-81; discussion 881-3. doi: 10.1016/j.athoracsur.2010.03.115. A multi-analyte serum test for the detection of non-small cell lung cancer Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, Warren WH, Bonomi P, Liptay MJ, Borgia JA Br J Cancer 2010 Oct 12 103(8):1221-8 Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival. Kim AW, Faber LP, Warren WH, Shah ND, Basu S, Liptay MJ. J Thorac Cardiovasc Surg. 2010 2010 Mar 139(3):606-11. doi: 10.1016/j.jtcvs.2009.05.044. Epub 2009 Aug 25. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Farlow EC, Patel K, Basu S, Lee BS, Kim AW, Coon JS, Faber LP, Bonomi P, Liptay MJ, Borgia JA. Clin Cancer Res. 2010 2010 Jul 1 16(13):3452-62. doi: 10.1158/1078-0432.CCR-09-3192. Epub 2010 Jun 22. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J. Int J Cancer. 2010 2010 Apr 1 126(7):1630-9. doi: 10.1002/ijc.24896. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. Hollings DD, Higgins RS, Faber LP, Warren WH, Liptay MJ, Basu S, Kim AW. Am J Surg. 2010 2010 Apr 199(4):558-61. doi: 10.1016/j.amjsurg.2009.11.006. Sentinel node mapping in lung cancer: introduction. Liptay MJ. Semin Thorac Cardiovasc Surg. 2009 2009 Winter 21(4):297. doi: 10.1053/j.semtcvs.2009.12.001. No abstract available. Right middle lobectomy for a primary pulmonary leiomyoma: a case report. Vercillo MS, Kim AW, Pitelka L, Gattuso P, Liptay MJ. Cases J. 2009 2009 Sep 8 2:8673. doi: 10.1186/1757-1626-0002-0000008673. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP. Ann Thorac Surg. 2009 2009 Sep 88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does side really matter? Kim AW, Faber LP, Warren WH, Basu S, Wightman SC, Weber JA, Bonomi P, Liptay MJ. Ann Thorac Surg. 2009 2009 Sep 88(3):937-43; discussion 944. doi: 10.1016/j.athoracsur.2009.04.102. An unusual case of Aspergillus fibrosing mediastinitis. Wightman SC, Kim AW, Proia LA, Faber LP, Gattuso P, Warren WH, Liptay MJ. Ann Thorac Surg. 2009 2009 Oct 88(4):1352-4. doi: 10.1016/j.athoracsur.2009.02.087. Enucleation of a giant esophageal gastrointestinal stromal tumor. Milman S, Kim AW, Farlow E, Liptay MJ. Ann Thorac Surg. 2009 2009 May 87(5):1603-5. doi: 10.1016/j.athoracsur.2008.09.010. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. Borgia JA, Basu S, Faber LP, Kim AW, Coon JS, Kaiser-Walters KA, Fhied C, Thomas S, Rouhi O, Warren WH, Bonomi P, Liptay MJ. J Thorac Oncol. 2009 2009 Mar 4(3):338-47. doi: 10.1097/JTO.0b013e3181982abf. Simultaneous costal cartilage-sparing modified Ravitch procedure and latissimus dorsi transfer for chest wall deformity repair in Poland's syndrome. Dingeldein MW, Lu CY, Kim AW, Ostric S, Liptay MJ, Holterman MJ. J Pediatr Surg. 2009 2009 Jan 44(1):e29-32. doi: 10.1016/j.jpedsurg.2008.10.068. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. Liptay MJ, D'amico TA, Nwogu C, Demmy TL, Wang XF, Gu L, Litle VR, Swanson SJ, Kohman LJ; Thoracic Surgery Subcommittee of the Cancer and Leukemia Group B. J Thorac Oncol. 2009 2009 Feb 4(2):198-202. doi: 10.1097/JTO.0b013e318194a2c3. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, Hammoud ZT, Kim AW. J Surg Oncol. 2009 2009 Dec 15 100(8):703-7. doi: 10.1002/jso.21407. Cytologic features of adult spindle cell variant of rhabdomyosarcoma: a report of two cases. Patel A, Placido JB, Pitelka L, Gattuso P, Liptay M, Kim A. Diagn Cytopathol. 2009 2009 Dec 37(12):932-4. doi: 10.1002/dc.21189. No abstract available. Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies. Kim AW, Liptay MJ, Saclarides TJ, Warren WH. Interact Cardiovasc Thorac Surg. 2009 2009 Aug 9(2):379-81. doi: 10.1510/icvts.2009.207555. Epub 2009 May 8. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial. Kim AW, Faber LP, Warren WH, Saclarides TJ, Carhill AA, Basu S, Choh MS, Liptay MJ. Surgery. 2008 2008 Oct 144(4):712-7; discussion 717-8. doi: 10.1016/j.surg.2008.07.007. Epub 2008 Aug 29. Contemporary review on the inequities in the management of lung cancer among the African-American population. Kim AW, Liptay MJ, Higgins RS. J Natl Med Assoc. 2008 2008 Jun 100(6):683-8. Review. Utility of silicone esophageal bypass stents in the management of delayed complex esophageal disruptions. Kim AW, Liptay MJ, Snow N, Donahue P, Warren WH. Ann Thorac Surg. 2008 2008 Jun 85(6):1962-7; discussion 1967. doi: 10.1016/j.athoracsur.2008.02.043. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion Warren WH, Kim AW, Liptay MJ Eur J Cardiothorac Surg 2008 Jan 33(1):89-94 Sentinel node mapping in lung cancer: the Holy Grail? Liptay MJ. Ann Thorac Surg. 2008 2008 Feb 85(2):S778-9. doi: 10.1016/j.athoracsur.2007.10.103. Review. No abstract available. Cytologic imprints of giant atypical bronchopulmonary carcinoid tumor of the lung with extensive oncocytic component. McIntire M, Shah ND, Kim AW, Gattuso P, Liptay MJ. Diagn Cytopathol. 2008 2008 Dec 36(12):887-90. doi: 10.1002/dc.20946. Invited commentary. Liptay MJ. Ann Thorac Surg. 2008 2008 Aug 86(2):395. doi: 10.1016/j.athoracsur.2008.05.067. No abstract available.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received
30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the
section of the Rush University Medical Center website.
To watch a brief video of Michael J. Liptay, MD, click the play button at the lower left corner of the video frame below.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
When a patient shows up in our thoracic surgery office at University Thoracic Surgeons, they’re often facing the most difficult health issue of their life. I think the thing that we’re blessed with is a team of committed individuals that recognize that and handle the patients with a great deal of empathy and care. And what we’re able to demonstrate to them is that they found in us a partner in fighting this.
Lung cancer was really thought to — and still does in some cases — carry a very grave prognosis. That said, if it’s caught early enough — which we’re doing much more these days — operating — often with minimally invasive techniques — allows the patients to begin with a very frightening diagnosis and come out at the other end cured.